ArticleChembiochem : a European journal of chemical biology2026
Structural and Dynamics Insights into Melatonin Binding to MT1 Receptor.
Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural and Dynamics Insights into Melatonin Binding to MT1 Receptor.Chembiochem : a European journal of chemical biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Melatonin (MLT) (N-acetyl-5-methoxytryptamine), mainly acting through its two receptors MT1 and MT2, plays a crucial role in regulating circadian rhythms. In addition, MLT has antidepressant, anti-inflammatory, anti-tumor, antioxidant, locomotor activity-regulating, vascular, and neuroprotective effects. Despite recent reports on X-ray free-electron laser and cryo-EM structures of MT1 receptor in complex with agonists, such as agomelatine, 2-phenylmelatonin and ramelteon, a detailed high-resolution description of the MT1 binding by melatonin under near to native (physiological) conditions is still missing. To this aim, we used isolated cellular membranes overexpressing MT1 receptors to conduct a high-resolution nuclear magnetic resonance interaction study. Combined with computational methodologies such as homology modeling, molecular docking and molecular dynamics simulations, this approach provides significant structural and dynamical insights into the interaction between MT1 receptor and melatonin. We found that MLT interacts, through hydrophobic interactions, with the orthosteric binding pocket enhancing receptor motions that in turn facilitate local rearrangements in the cytoplasmic portion of MT1.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.